Our data clearly revealed that chelerythrine and sanguinarine irreversibly inhibit the activity of TXNRD1 while specifically targeting Sec498 of the enzyme, presenting significant anti-cancer activities through necroptotic cell death. This evidence concerns the gene TXNRD1 and cancer.